D Venzon
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- Cancer Treatment and Pharmacology
Papers in
-
- Lymphoma Diagnosis and Treatment 2
-
- Respiratory Support and Mechanisms 1
- Co-authors
- Nita L. Seibel (3 shared papers)Michael L. Nieder (3 shared papers)Joseph E. Gootenberg (3 shared papers)Carola Arndt (3 shared papers)Aziza Shad (3 shared papers)Ivan D. Horak (3 shared papers)J E Neely (2 shared papers)Magdalena Adde (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal of Applied Physiology (1 paper)PubMed (2 papers)
- Partner nations
- United StatesMalaysia
In The Last Decade
D Venzon
7 papers receiving 702 citations
Peers
Comparison fields: 5 of 75
- Pathology and Forensic Medicine 321
- Oncology 325
- Genetics 120
- Neurology 153
- Cardiology and Cardiovascular Medicine 149
Countries citing papers authored by D Venzon
This map shows the geographic impact of D Venzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Venzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Venzon more than expected).
Fields of papers citing papers by D Venzon
This network shows the impact of papers produced by D Venzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Venzon. The network helps show where D Venzon may publish in the future.
Co-authors
The 25 scholars most cited alongside D Venzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 317 | |
| 2 | 1996 | 171 | |
| 3 | Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. | 1992 | 73 |
| 4 | 1992 | 72 | |
| 5 | Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas. | 1998 | 43 |
| 6 | 1996 | 39 | |
| 7 | 1990 | 10 |
About D Venzon
D Venzon is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Public Health, Environmental and Occupational Health and Hematology, having authored 7 papers that have together received 725 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer Treatment and Pharmacology (1 paper), Acute Myeloid Leukemia Research (1 paper), Respiratory Support and Mechanisms (1 paper), Thermal Regulation in Medicine (1 paper), Hematological disorders and diagnostics (1 paper) and Polymer Nanocomposite Synthesis and Irradiation (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (321 citations), Oncology (325 citations), Genetics (120 citations), Neurology (153 citations) and Cardiology and Cardiovascular Medicine (149 citations). D Venzon has collaborated with scholars based in United States and Malaysia. Frequent co-authors include Nita L. Seibel, Michael L. Nieder, Joseph E. Gootenberg, Carola Arndt, Aziza Shad, Ivan D. Horak, J E Neely, Magdalena Adde, Ian Magrath and Elaine S. Jaffe. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Applied Physiology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.